SARS-CoV-2 Spike RBD Nanobody Recombinant Antibody
The SARS-CoV-2 Spike RBD Nanobody Recombinant Antibody is applicable for the following applications: ELISA, GICA, Neutralising. Host: Human. Species Reactivity: Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) . Immunogen: Recombinant Human Novel Coronavirus Spike glycoprotein (S) (319-541aa) . Accession Number: P0DTC2. Target Synonyms: S; S1; S1-RBD; Spike glycoprotein. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
Short Description
The SARS-CoV-2 Spike RBD Nanobody Recombinant Antibody is applicable for the following applications: ELISA, GICA, Neutralising.
Accession Number
P0DTC2
Host
Human
Reactivity
Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
Immunogen
Recombinant Human Novel Coronavirus Spike glycoprotein (S) (319-541aa)
Target
S
Clonality
Recombinant Monoclonal
Clone
A1
Conjugation
Unconjugated. Conjugated antibodies are available (Biotin, FITC and HRP), please inquire.
Applications
ELISA, GICA, Neutralising
Field of Research
Microbiology
Purification
Affinity chromatography
Concentration
Lot specific. Please inquire or refer to the datasheet included in the product pouch.
Format
Liquid
Buffer
0.03% Proclin 300, 50% glycerol, 0.01M PBS, pH 7.4
Shipping Conditions
Ice packs
Storage Conditions
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Fragment
VHH-Fc
Target Alternative Name
S; S1; S1-RBD; Spike glycoprotein
Species
Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Cluster Of Differentiation 5 (CD5)